Immunologists are at the core of understanding how the body defends itself against disease, providing essential insights that guide the development of vaccines, treatments, and diagnostics. By studying the immune system’s responses to pathogens, allergens, and even the body’s own cells, they help uncover mechanisms that can be targeted to prevent or treat illness. Their work spans both laboratory and clinical settings, where they explore cellular behavior, antibody production, and immune memory to advance medical science. Immunologists are crucial in identifying immune deficiencies, autoimmune conditions, and inflammatory disorders, which directly contributes to improving patient outcomes and quality of life.
In the field of infectious disease control, immunologists play a vital role by guiding how immune responses can be harnessed to combat viruses, bacteria, and other threats. Their research often lays the foundation for vaccine development and effectiveness testing, ensuring that immunization strategies are backed by robust scientific evidence. They collaborate with public health professionals, researchers, and biotechnologists to translate findings into practical health solutions. As new health threats emerge, immunologists continue to adapt and innovate, using cutting-edge technologies like immunogenomics and systems biology. Their contributions not only advance therapeutic science but also enhance global health resilience, making their work indispensable in both prevention and treatment strategies worldwide.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States